Dick C. Chan

7.8k total citations
201 papers, 6.0k citations indexed

About

Dick C. Chan is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Dick C. Chan has authored 201 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Surgery, 122 papers in Endocrinology, Diabetes and Metabolism and 64 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Dick C. Chan's work include Lipoproteins and Cardiovascular Health (123 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (114 papers) and Cancer, Lipids, and Metabolism (54 papers). Dick C. Chan is often cited by papers focused on Lipoproteins and Cardiovascular Health (123 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (114 papers) and Cancer, Lipids, and Metabolism (54 papers). Dick C. Chan collaborates with scholars based in Australia, United States and Sweden. Dick C. Chan's co-authors include Gerald F. Watts, P. Hugh R. Barrett, Esther Ooi, T Ng, Jing Pang, Trevor A. Mori, Trevor G. Redgrave, Lawrence J. Beilin, Gursharan Dogra and Minh N. Nguyen and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and American Journal of Clinical Nutrition.

In The Last Decade

Dick C. Chan

197 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dick C. Chan Australia	46	3.1k	2.7k	1.7k	1.2k	1.1k	201	6.0k
Hubert Scharnagl Austria	49	2.6k 0.8×	1.8k 0.7×	1.6k 0.9×	1.3k 1.1×	794 0.7×	265	7.4k
Jean‐Marie Bard France	42	2.6k 0.8×	3.3k 1.2×	2.4k 1.4×	781 0.7×	949 0.9×	170	7.2k
Robin P. F. Dullaart Netherlands	48	2.0k 0.6×	3.4k 1.2×	1.1k 0.7×	1.3k 1.1×	541 0.5×	251	6.6k
Anette Varbo Denmark	34	3.5k 1.1×	3.2k 1.2×	1.9k 1.1×	943 0.8×	1.2k 1.1×	57	5.8k
Ioanna Gouni‐Berthold Germany	37	4.1k 1.3×	1.8k 0.7×	1.6k 0.9×	613 0.5×	926 0.9×	156	7.5k
Theodore Mazzone United States	40	2.2k 0.7×	2.8k 1.0×	1.9k 1.1×	1.4k 1.2×	545 0.5×	107	7.2k
Gérald Luc France	46	3.1k 1.0×	2.6k 0.9×	3.0k 1.7×	1.1k 0.9×	1.1k 1.0×	88	9.1k
Marian C. Cheung United States	38	3.0k 1.0×	3.2k 1.2×	930 0.5×	631 0.5×	1.2k 1.1×	74	5.9k
Jean Bergeron Canada	33	3.3k 1.1×	1.8k 0.7×	1.1k 0.7×	746 0.6×	557 0.5×	81	6.1k
Sergio Fazio United States	44	4.6k 1.5×	2.3k 0.8×	1.9k 1.1×	890 0.8×	1.2k 1.1×	143	8.0k

Countries citing papers authored by Dick C. Chan

Since Specialization

Citations

This map shows the geographic impact of Dick C. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dick C. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dick C. Chan more than expected).

Fields of papers citing papers by Dick C. Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dick C. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dick C. Chan. The network helps show where Dick C. Chan may publish in the future.

Co-authorship network of co-authors of Dick C. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Dick C. Chan. A scholar is included among the top collaborators of Dick C. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dick C. Chan. Dick C. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chan, Dick C., et al.. (2026). Hypertriglyceridemia: updates from clinical trials of new agents and real-world registries. Current Opinion in Endocrinology Diabetes and Obesity. 33(2). 66–76.

Chan, Dick C., Jing Pang, Gerald F. Watts, et al.. (2025). Triglyceride to High-Density Lipoprotein Cholesterol Ratio as a Marker of Subclinical Coronary Atherosclerosis and Hepatic Steatosis in Familial Hypercholesterolemia. Endocrine Practice. 31(6). 776–783. 1 indexed citations

Watts, Gerald F. & Dick C. Chan. (2025). Reaching for the stars: a wider perspective for designing future cardiovascular outcome trials of triglyceride-lowering therapies. European Heart Journal. 46(19). 1849–1851. 2 indexed citations

Pang, Jing, Alan Woodward, Damon A. Bell, et al.. (2025). Enhancing the detection of familial hypercholesterolaemia in general practice: A model for supporting genetic cascade testing in the community. European Journal of Human Genetics. 34(2). 252–259.

Harray, Amelia J., Lelinh Duong, S. Herrmann, et al.. (2025). Randomised controlled trial of a low plastic diet and lifestyle intervention for adults with cardiometabolic risk factors: the Plastic Exposure Reduction Transforms Health (PERTH) trial – a protocol. BMJ Open. 15(8). e099330–e099330.

Caparrós‐Martín, José A., Natalie C. Ward, Montserrat Saladié, et al.. (2024). An Analysis of the Gut Microbiota and Related Metabolites following PCSK9 Inhibition in Statin-Treated Patients with Elevated Levels of Lipoprotein(a). Microorganisms. 12(1). 170–170. 3 indexed citations

Loh, Wann Jia, Dick C. Chan, Jing Pang, et al.. (2024). Opportunistic Detection of Phytosterolemia During Genetic Testing for FH: Case Series and Contextual Review. The Journal of Clinical Endocrinology & Metabolism. 110(5). 1358–1364. 2 indexed citations

Ward, Natalie C., Qidi Ying, Dick C. Chan, et al.. (2023). Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): Selective effect of eicosapentaenoic acid?. Journal of clinical lipidology. 17(5). 694–699. 8 indexed citations

Loh, Wann Jia, Jing Pang, Anindita Chakraborty, et al.. (2023). Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial hypercholesterolaemia. Journal of clinical lipidology. 18(1). e33–e37. 5 indexed citations

10.

Pang, Jing, Frank Sanfilippo, Dick C. Chan, & Gerald F. Watts. (2023). Adherence to pharmacotherapy: sine qua non for reducing cumulative risk of premature coronary disease in familial hypercholesterolemia. Current Opinion in Endocrinology Diabetes and Obesity. 31(1). 22–30. 3 indexed citations

11.

Chemello, Kévin, et al.. (2022). Recent advances in demystifying the metabolism of lipoprotein(a). Atherosclerosis. 349. 82–91. 35 indexed citations

12.

Page, Michael M., Katrina L. Ellis, Dick C. Chan, et al.. (2022). A variant in the fibronectin (FN1) gene, rs1250229-T, is associated with decreased risk of coronary artery disease in familial hypercholesterolaemia. Journal of clinical lipidology. 16(4). 525–529. 3 indexed citations

13.

Chakraborty, Anindita, Dick C. Chan, Katrina L. Ellis, et al.. (2022). Cascade testing for elevated lipoprotein(a) in relatives of probands with high lipoprotein(a). SHILAP Revista de lepidopterología. 10. 100343–100343. 13 indexed citations

14.

Brett, Tom, Dick C. Chan, Jan Radford, et al.. (2021). Improving detection and management of familial hypercholesterolaemia in Australian general practice. Heart. 107(15). 1213–1219. 15 indexed citations

15.

Page, Michael M., Katrina L. Ellis, Jing Pang, et al.. (2020). Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemia. Clinica Chimica Acta. 510. 211–215. 11 indexed citations

16.

Chan, Dick C., et al.. (2019). Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma Lipoprotein(a) Concentration. The Journal of Clinical Endocrinology & Metabolism. 104(12). 6247–6255. 13 indexed citations

17.

Chan, Dick C., Gerald F. Watts, Ransi Somaratne, et al.. (2018). Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism. Arteriosclerosis Thrombosis and Vascular Biology. 38(7). 1644–1655. 28 indexed citations

18.

Chan, Dick C. & Gerald F. Watts. (2010). Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies. Expert Opinion on Pharmacotherapy. 12(1). 13–30. 53 indexed citations

19.

Chan, Dick C., et al.. (2008). An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?. International Journal of Clinical Practice. 62(5). 799–809. 62 indexed citations

20.

Ng, P C, Gary Wong, Christopher Wai Kei Lam, et al.. (1997). Pituitary-Adrenal Suppression and Recovery in Preterm Very Low Birth Weight Infants after Dexamethasone Treatment for Bronchopulmonary Dysplasia. The Journal of Clinical Endocrinology & Metabolism. 82(8). 2429–2432. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact